Waters Corp. and BD announced a definitive agreement July 14 to combine BD’s Biosciences & Diagnostic Solutions businesses with the Milford, Mass.-based company. The deal is structured as a ...

The president of BD’s life sciences division, Dave Hickey, is officially planning his retirement, with the calendar marked for July 1. Hickey has overseen BD’s portfolio of scientific research tools ...

BD (BDX), the MedTech firm also known as Becton, Dickinson, traded lower in the premarket on Monday despite posting better-than-expected financials for Q1 fiscal 2026, as its life sciences segment ...

FRANKLIN LAKES, N.J., Aug. 12, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Michael Feld has been named ...

BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics, and the delivery of care. BD leads in patient and healthcare worker safety ...

BD Life Sciences, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), today announced it has completed the acquisition of Cellular Research, Inc. BD ...

BD demonstrated how its portfolio supports the evolving needs of pharmaceutical and biotechnology companies developing biologics – GLP-1 therapies, vaccines, and acute care medicines – as the industry ...

Becton, Dickinson and Company BDX, popularly known as BD, is evaluating the divestment of its Life Sciences division as part of a broader strategic shift toward becoming a pure-play medtech company.